Selected research
Industry Research
Favipiravir Industry Research Report 2026
Market perspective
The global Favipiravir market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Favipiravir is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Favipiravir is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Favipiravir include ChemRar Group, Cipla, Dr. Reddy, Fujifilm, Glenmark, Lupin, R-Pharma, Sun Pharma and Hisun Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Favipiravir market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Favipiravir Market by Company
ChemRar Group
Cipla
Dr. Reddy
Fujifilm
Glenmark
Lupin
R-Pharma
Sun Pharma
Hisun Pharm
Favipiravir Segment by Type
Brand Drug
Generic Drug
Favipiravir Segment by Application
Influenza Viruses
COVID-19
Others
Favipiravir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Favipiravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Favipiravir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Favipiravir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Favipiravir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Favipiravir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Favipiravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brand Drug
- Generic Drug
Applications
- Influenza Viruses
- COVID-19
- Others
Companies covered
- ChemRar Group
- Cipla
- Dr. Reddy
- Fujifilm
- Glenmark
- Lupin
- R-Pharma
- Sun Pharma
- Hisun Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Favipiravir Market Size (2021-2032)
- 2.2.2 Global Favipiravir Sales (2021-2032)
- 2.2.3 Global Favipiravir Market Average Price (2021-2032)
- 2.3 Favipiravir by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Brand Drug
- 2.3.3 Generic Drug
- 2.4 Favipiravir by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Influenza Viruses
- 2.4.3 COVID-19
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Favipiravir Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Favipiravir Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Favipiravir Revenue of Manufacturers (2021-2026)
- 3.4 Global Favipiravir Average Price by Manufacturers (2021-2026)
- 3.5 Global Favipiravir Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Favipiravir, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Favipiravir, Product Type & Application
- 3.8 Global Manufacturers of Favipiravir, Established Date
- 3.9 Global Favipiravir Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ChemRar Group
- 4.1.1 ChemRar Group Company Information
- 4.1.2 ChemRar Group Business Overview
- 4.1.3 ChemRar Group Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ChemRar Group Favipiravir Product Portfolio
- 4.1.5 ChemRar Group Recent Developments
- 4.2 Cipla
- 4.2.1 Cipla Company Information
- 4.2.2 Cipla Business Overview
- 4.2.3 Cipla Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cipla Favipiravir Product Portfolio
- 4.2.5 Cipla Recent Developments
- 4.3 Dr. Reddy
- 4.3.1 Dr. Reddy Company Information
- 4.3.2 Dr. Reddy Business Overview
- 4.3.3 Dr. Reddy Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dr. Reddy Favipiravir Product Portfolio
- 4.3.5 Dr. Reddy Recent Developments
- 4.4 Fujifilm
- 4.4.1 Fujifilm Company Information
- 4.4.2 Fujifilm Business Overview
- 4.4.3 Fujifilm Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fujifilm Favipiravir Product Portfolio
- 4.4.5 Fujifilm Recent Developments
- 4.5 Glenmark
- 4.5.1 Glenmark Company Information
- 4.5.2 Glenmark Business Overview
- 4.5.3 Glenmark Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Glenmark Favipiravir Product Portfolio
- 4.5.5 Glenmark Recent Developments
- 4.6 Lupin
- 4.6.1 Lupin Company Information
- 4.6.2 Lupin Business Overview
- 4.6.3 Lupin Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lupin Favipiravir Product Portfolio
- 4.6.5 Lupin Recent Developments
- 4.7 R-Pharma
- 4.7.1 R-Pharma Company Information
- 4.7.2 R-Pharma Business Overview
- 4.7.3 R-Pharma Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 R-Pharma Favipiravir Product Portfolio
- 4.7.5 R-Pharma Recent Developments
- 4.8 Sun Pharma
- 4.8.1 Sun Pharma Company Information
- 4.8.2 Sun Pharma Business Overview
- 4.8.3 Sun Pharma Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharma Favipiravir Product Portfolio
- 4.8.5 Sun Pharma Recent Developments
- 4.9 Hisun Pharm
- 4.9.1 Hisun Pharm Company Information
- 4.9.2 Hisun Pharm Business Overview
- 4.9.3 Hisun Pharm Favipiravir Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hisun Pharm Favipiravir Product Portfolio
- 4.9.5 Hisun Pharm Recent Developments
5 Global Favipiravir Market Scenario by Region
- 5.1 Global Favipiravir Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Favipiravir Sales by Region: 2021-2032
- 5.2.1 Global Favipiravir Sales by Region: 2021-2026
- 5.2.2 Global Favipiravir Sales by Region: 2027-2032
- 5.3 Global Favipiravir Revenue by Region: 2021-2032
- 5.3.1 Global Favipiravir Revenue by Region: 2021-2026
- 5.3.2 Global Favipiravir Revenue by Region: 2027-2032
- 5.4 North America Favipiravir Market Facts & Figures by Country
- 5.4.1 North America Favipiravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Favipiravir Sales by Country (2021-2032)
- 5.4.3 North America Favipiravir Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Favipiravir Market Facts & Figures by Country
- 5.5.1 Europe Favipiravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Favipiravir Sales by Country (2021-2032)
- 5.5.3 Europe Favipiravir Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Favipiravir Market Facts & Figures by Country
- 5.6.1 Asia Pacific Favipiravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Favipiravir Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Favipiravir Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Favipiravir Market Facts & Figures by Country
- 5.7.1 South America Favipiravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Favipiravir Sales by Country (2021-2032)
- 5.7.3 South America Favipiravir Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Favipiravir Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Favipiravir Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Favipiravir Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Favipiravir Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Favipiravir Sales by Type (2021-2032)
- 6.1.1 Global Favipiravir Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Favipiravir Sales Market Share by Type (2021-2032)
- 6.2 Global Favipiravir Revenue by Type (2021-2032)
- 6.2.1 Global Favipiravir Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Favipiravir Revenue Market Share by Type (2021-2032)
- 6.3 Global Favipiravir Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Favipiravir Sales by Application (2021-2032)
- 7.1.1 Global Favipiravir Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Favipiravir Sales Market Share by Application (2021-2032)
- 7.2 Global Favipiravir Revenue by Application (2021-2032)
- 7.2.1 Global Favipiravir Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Favipiravir Revenue Market Share by Application (2021-2032)
- 7.3 Global Favipiravir Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Favipiravir Value Chain Analysis
- 8.1.1 Favipiravir Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Favipiravir Production Mode & Process
- 8.2 Favipiravir Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Favipiravir Distributors
- 8.2.3 Favipiravir Customers
9 Global Favipiravir Analyzing Market Dynamics
- 9.1 Favipiravir Industry Trends
- 9.2 Favipiravir Industry Drivers
- 9.3 Favipiravir Industry Opportunities and Challenges
- 9.4 Favipiravir Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst